Divya Mathur

Divya joined TRV as an Entrepreneur-in-Residence in 2023, focusing on building new companies in the biotherapeutics area. She is fascinated by clever, elegant ways to design novel biotherapeutics with enhanced efficacy and safety. Divya started her industry career at Pfizer Oncology, where she spent a number of years leading tumor targeted biotherapeutics programs (T cell engagers, ADCs) from target discovery to early clinical development. Subsequently, she served as Director of Immuno-Oncology at Regeneron Pharmaceuticals, where she established a group focused on identifying novel antibody-based strategies to modulate the immune-suppressive tumor microenvironment and develop next-generation platforms for immune engagers and immunocytokines with improved therapeutic potential.

Divya received her Ph.D. in Biology at MIT studying stem cell biology. Continuing with her interest in understanding cell fate specification, she did her postdoctoral work at Columbia University Medical Center. Using the power of Drosophila genetics to track lineage specification, her work led to the first identification of a developmental niche for intestinal stem cells. Divya is continually amazed by the precision with which molecular events orchestrate the fate of cells and tissues during development, and how perturbations in these events can contribute to disease. She is passionate about studying these molecular events in disease settings, finding smart solutions to design effective therapeutic strategies.

Outside of her scientific work, Divya enjoys experimenting with new cuisines and dabbling in various craft projects. She is also an active volunteer in the local community. She loves spending time with her wonderful husband and two daughters, traveling with them to new places and exploring life’s adventures.